(Q33663249)

28 July 2017

title

Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test (English)

1 reference

carcinoma of unknown primary

28 July 2017

main subject

1 reference

Federico A Monzon

1 reference

28 July 2017

Fabiola Medeiros

series ordinal

1 reference

28 July 2017

Maureen Lyons-Weiler

series ordinal

1 reference

28 July 2017

W David Henner

series ordinal

1 reference

28 July 2017

publication date

13 January 2010

1 reference

28 July 2017

1 reference

28 July 2017

1 reference

28 July 2017

1 reference

Creative Commons Attribution 2.0 Generic

28 July 2017

start time

13 January 2010

1 reference

April 2022 Public Data File from Crossref

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Carcinoma of Unknown Primary Treatment (PDQ®): Health Professional Version

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

Synchronous bilateral invasive lobular breast cancer presenting as carcinomatosis in a male

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: a systematic literature review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

Carcinoma of unknown primary (CUP).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

MicroRNAs accurately identify cancer tissue origin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

21 June 2018

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

Interlaboratory performance of a microarray-based gene expression test to determine tissue of origin in poorly differentiated and undifferentiated cancers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

Tissue handling for genome-wide expression analysis: a review of the issues, evidence, and opportunities

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

Cancer of unknown primary origin: a decade of experience in a community-based hospital

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

Cancer of unknown primary site: missing primary or missing biology?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

Diagnostic strategies for unknown primary cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

Multi-platform, multi-site, microarray-based human tumor classification

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

Diagnostic and therapeutic management of cancer of an unknown primary

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

Identifying tumor origin using a gene expression-based classification map.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

Multiclass cancer diagnosis using tumor gene expression signatures

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

Male breast cancer in the veterans affairs population: a comparative analysis

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

Molecular classification of human cancers using a 92-gene real-time quantitative polymerase chain reaction assay

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

Comparative study of primary mammary small cell carcinoma, carcinoma with endocrine features and invasive ductal carcinoma.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: a Minnie Pearl Cancer Research Network study

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

Molecular classification of human carcinomas by use of gene expression signatures.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823680

Carcinoma of unknown primary with a colon-cancer profile-changing paradigm and emerging definitions

30 October 2018

1 reference

12 December 2020

Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary

1 reference

12 December 2020

Multicenter validation of a 1,550-gene expression profile for identification of tumor tissue of origin

1 reference

12 December 2020

The need to consider survival, outcome, and expense when evaluating and treating patients with unknown primary carcinoma

1 reference

12 December 2020

Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site

1 reference

12 December 2020

Unknown primary tumors metastatic to liver

1 reference

12 December 2020

Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin

1 reference

12 December 2020

Phase II trial of bevacizumab and erlotinib in carcinomas of unknown primary site: the Minnie Pearl Cancer Research Network

1 reference

12 December 2020

Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma

1 reference

12 December 2020

Raising the profile of cancer of unknown primary

1 reference

12 December 2020

Identifiers

DOI

10.1186/1746-1596-5-3

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference